A critical question for cancer therapy: what new targets exist?

Designing molecular targeted therapy with high specificity based on novel tumor biomarkers is a high priority in lung cancer research. Several molecular aberrations have been already identified in non-small cell lung cancer (NSCLC), with subsequent development of drugs targeted to these aberrations....

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Transl Lung Cancer Res
Hlavní autoři: Rosell, Rafael, Karachaliou, Niki, Codony, Jordi, Teixido, Cristina, Garcia-Roman, Silvia, Morales, Daniela, Cao, María González, Viteri, Santiago, Veliz, Ignacio, Loo, Yong, Castillo, Omar
Médium: Artigo
Jazyk:Inglês
Vydáno: Pioneer Bioscience Publishing Company 2014
Témata:
Editorial
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4367674/
https://ncbi.nlm.nih.gov/pubmed/25806328
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3978/j.issn.2218-6751.2014.08.10
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky